Table 3.
Filled prescriptions of opioids categorised in four groups according to Defined Daily Dose (DDDd), among Sami and non- Sami women who reported chronic musculoskeletal pain, the SAMINOR 2 Questionnaire Survey (2012) and the Norwegian Prescription Database (2012–2019).
Sami |
Non-Sami |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
No prescriptions |
≤180 DDD 1 prescription |
≤180 DDD 2 or more prescriptions |
>180 DDD |
No prescriptions |
≤180 DDD 1 prescription |
≤180 DDD 2 or more prescriptions |
>180 DDD |
|||
Year | n | % (n) | % (n) | % (n) | % (n) | % (n) | % (n) | % (n) | % (n) | P-valuea |
2012b | 2879 | 81.3 (505) | 7.2 (45) | 9.0 (56) | 2.4 (15) | 79.8 (1802) | 9.9 (223) | 8.5 (193) | 1.8 (40) | .18 |
2013b | 2868 | 80.6 (499) | 7.6 (47) | 9.5 (59) | 2.3 (14) | 79.5 (1788) | 9.4 (211) | 9.2 (208) | 1.9 (42) | .53 |
2014b | 2859 | 78.6 (485) | 9.7 (60) | 9.2 (57) | 2.4 (15) | 80.1 (1796) | 9.6 (216) | 7.6 (170) | 2.7 (60) | .59 |
2015b | 2846 | 78.6 (485) | 9.9 (61) | 8.9 (55) | 2.6 (16) | 78.1 (1741) | 11.8 (263) | 7.7 (171) | 2.4 (54) | .46 |
2016b | 2830 | 80.2 (493) | 9.3 (57) | 7.8 (48) | 2.8 (17) | 80.1 (1775) | 9.2 (204) | 8.4 (186) | 2.3 (50) | .87 |
2017b | 2814 | 80.0 (489) | 8.7 (53) | 8.2 (50) | 3.1 (19) | 80.2 (1766) | 9.2 (202) | 8.3 (182) | 2.4 (53) | .79 |
2018c | 2812 | 79.7 (486) | 9.5 (58) | 8.7 (53) | 2.1 (13) | 77.8 (1714) | 11.8 (259) | 8.3 (182) | 2.1 (47) | .48 |
2019c | 2806 | 82.9 (505) | 5.7 (35) | 9.4 (57) | 2.0 (12) | 80.9 (1777) | 9.1 (201) | 7.5 (165) | 2.5 (54) | .03 |
2012–2019 combined | 2806 | 49.8 (303) | 16.9 (103) | 25.6 (156) | 7.7 (47) | 44.9 (987) | 17.9 (393) | 30.0 (659) | 7.2 (158) | .11 |
2012–2019 combined, weak opioidsd | 2806 | 50.4 (307) | 17.1 (104) | 24.8 (151) | 7.7 (47) | 45.7 (1004) | 18.0 (396) | 29.4 (647) | 6.8 (150) | .08 |
2012–2019 combined, strong opioidse | 2806 | 94.9 (578) | 2.3 (14) | 2.1 (13) | 0.7 (4) | 92.7 (2037) | 2.5 (55) | 3.8 (84) | 1.0 (21) | .19 |
Abbreviations: DDD, Defined Daily Dose; aComparing Sami and non-Sami by Pearson’s chi-square test; bexcluded persons who died, emigrated, or received palliative treatment; cexcluded persons who died or received palliative treatment. dWeak opioids includes ATC codes N02AJ, N02AX02; eStrong opioids includes ATC codes N02AA, N02AB, N02AC, N02AD01 N02AE, N02AG, N02AX06.